Recent studies have suggested Nociceptin/Orphanin FQ (N/OFQ) system, a functional antagonist of corticotrophin-releasing factor, as therapeutic target either obesity or BED. This evidence concerns the gene PNOC and X-linked cone dysfunction syndrome with myopia.